Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease
- 1Department of Neurology, University of Turku, Finland
- 2Department of Radiology, University of Turku
- 3Turku PET Centre, Turku
- Correspondence to: Dr Juha O Rinne, Turku PET Centre, PO Box 52, FIN-20521, Turku, Finland;
- Received 24 April 2002
- Accepted 12 September 2002
- Revised 30 August 2002
Objective: Brain acetylcholinesterase activity was determined in healthy controls and in patients with mild cognitive impairment and early Alzheimer’s disease.
Methods: A specific acetylcholinesterase tracer, [methyl-11C]N-methyl-piperidyl-4-acetate ([11C]MP4A), and a three dimensional PET system with magnetic resonance coregistration were used for imaging.
Results: There was a significant difference in the acetylcholinesterase activity in the hippocampus between the groups (p = 0.03), the mean (SD) acetylcholinesterase activity (k3 values, min−1) being 0.114 (0.036) in controls, 0.098 (0.023) in mild cognitive impairment, and 0.085 (0.022) in Alzheimer’s disease. The mini-mental state examination score showed no significant relation with acetylcholinesterase activity in any brain area in the combined mild cognitive impairment/Alzheimer group.
Conclusions: Hippocampal acetylcholinesterase activity is only slightly reduced in mild cognitive impairment and early Alzheimer’s disease and so the value of in vivo acetylcholinesterase measurements in detecting the early Alzheimer process is limited.
Competing interests: none declared